Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Passage BIO, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- −3 vs. Q1 2023
- Shares held
- 33.4M
- −2.18M (−6.1%) vs. Q1 2023
- Total value
- $31.4M
- −$2.64M (−7.8%) vs. Q1 2023
- New holders
- 8
- 9 more added
- Sold out
- 11
- 18 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $13.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.0M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1 | $1 | 0.00% | −33,167−100.0% | Reduced |
| First Capital Advisors Group, LLC. | 23 | $22 | 0.00% | +23 | New |
| Group One Trading, L.P. | 47 | $44 | 0.00% | −53−53.0% | Reduced |
| Clearstead Advisors, LLC | 75 | $71 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 217 | $204 | 0.00% | −1,390−86.5% | Reduced |
| Wells Fargo & Company | 244 | $230 | 0.00% | −290−54.3% | Reduced |
| US Bancorp | 500 | $471 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 783 | $736 | 0.00% | +783 | New |
| Steward Partners Investment Advisory, LLC | 1,010 | $951 | 0.00% | +1,010 | New |
| Royal Bank of Canada | 658 | $1.00K | 0.00% | +536+439.3% | Added |
| JPMorgan Chase & Co | 1,269 | $1.20K | 0.00% | −587,739−99.8% | Reduced |
| Federated Hermes, Inc. | 1,652 | $1.55K | 0.00% | −1,625−49.6% | Reduced |
| Tower Research Capital LLC (TRC) | 2,571 | $2.42K | 0.00% | −30,478−92.2% | Reduced |
| Federation des caisses Desjardins du Quebec | 8,000 | $7.53K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 13,153 | $12.4K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 13,647 | $12.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 20,608 | $19.4K | 0.00% | +20,608 | New |
| Veritable, L.P. | 23,045 | $21.7K | 0.00% | 00.0% | Unchanged |
| Cresset Asset Management, LLC | 23,725 | $22.3K | 0.00% | +23,725 | New |
| Deutsche Bank AG | 24,697 | $23.2K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 27,519 | $25.9K | 0.00% | −70.0% | Reduced |
| HighTower Advisors, LLC | 39,323 | $30.0K | 0.00% | −8,660−18.0% | Reduced |
| Cornercap Investment Counsel Inc | 49,767 | $46.8K | 0.01% | −51,721−51.0% | Reduced |
| Annandale Capital, LLC | 54,338 | $51.0K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 58,113 | $54.7K | 0.00% | −2,789−4.6% | Reduced |
| FMR LLC | 62,021 | $58.4K | 0.00% | +1,400+2.3% | Added |
| Squarepoint Ops LLC | 69,712 | $65.6K | 0.00% | +69,712 | New |
| Marquette Asset Management, LLC | 86,050 | $81.0K | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 86,448 | $81.4K | 0.00% | +25,470+41.8% | Added |
| Pale Fire Capital SE | 98,662 | $92.9K | 0.01% | +98,662 | New |
| Morgan Stanley | 111,201 | $104.7K | 0.00% | −159,971−59.0% | Reduced |
| Fiduciary Trust Co | 115,000 | $108.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 123,873 | $116.6K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 134,290 | $126.4K | 0.00% | −140,045−51.0% | Reduced |
| RBF Capital, LLC | 142,807 | $134.4K | 0.01% | +32,000+28.9% | Added |
| Millennium Management LLC | 207,463 | $195.3K | 0.00% | −90,627−30.4% | Reduced |
| Two Sigma Advisers, LP | 247,700 | $233.2K | 0.00% | −62,800−20.2% | Reduced |
| Two Sigma Investments, LP | 259,854 | $244.6K | 0.00% | −29,072−10.1% | Reduced |
| Tang Capital Management LLC | 300,000 | $282.4K | 0.04% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 331,914 | $312.4K | 0.00% | 00.0% | Unchanged |
| Weiss Multi-Strategy Advisers LLC | 367,696 | $346.0K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 389,600 | $366.7K | 0.01% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 418,173 | $393.6K | 0.23% | +418,173 | New |
| Acadian Asset Management LLC | 578,806 | $543.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 979,095 | $922.0K | 0.00% | +14,195+1.5% | Added |
| BlackRock Inc. | 1,055,222 | $993.3K | 0.00% | +1,223+0.1% | Added |
| Lynx1 Capital Management LP | 1,167,343 | $1.10M | 0.72% | −2,240,255−65.7% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,850,000 | $1.74M | 0.10% | −1,906,915−50.8% | Reduced |
| Vanguard Group Inc | 2,017,883 | $1.90M | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 2,058,767 | $1.94M | 1.74% | +1,721,300+510.1% | Added |
| Erste Asset Management GmbH | 2,160,800 | $2.03M | 0.04% | +600,000+38.4% | Added |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $2.35M | 2.02% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 4,959,769 | $4.67M | 5.54% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 10,124,576 | $9.53M | 0.19% | +1,192,577+13.4% | Added |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −665,221−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −130,188−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −82,895−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −27,758−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −19,723−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −18,114−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −16,568−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,129−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −318−100.0% | Sold out |